0001450324-19-000005.txt : 20190130
0001450324-19-000005.hdr.sgml : 20190130
20190130113637
ACCESSION NUMBER: 0001450324-19-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190128
FILED AS OF DATE: 20190130
DATE AS OF CHANGE: 20190130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STRAYER DAVID R
CENTRAL INDEX KEY: 0001270074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-27072
FILM NUMBER: 19550871
MAIL ADDRESS:
STREET 1: 600 MAIN STREET
STREET 2: SUITE 2
CITY: RIVERTON
STATE: NJ
ZIP: 08077
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC
CENTRAL INDEX KEY: 0000946644
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 520845822
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2117 SW HIGHWAY 484
CITY: OCALA
STATE: FL
ZIP: 32801
BUSINESS PHONE: 215-988-0080
MAIL ADDRESS:
STREET 1: 2117 SW HIGHWAY 484
CITY: OCALA
STATE: FL
ZIP: 32801
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-01-28
0
0000946644
HEMISPHERX BIOPHARMA INC
HEB
0001270074
STRAYER DAVID R
600 MAIN STREET
SUITE 2
RIVERTON
NJ
08077
0
1
0
0
Chief Science/Medical Officer
Options to buy Common Stock
0.22
2019-01-28
4
A
0
184659
0
A
2019-01-28
2029-01-28
Common Stock
184659
184659
D
This option is being issued to senior management for a voluntary 50% deferral in salary.
David R. Strayer
2019-01-30